Skip to main content

Pharmacoresistance in Epilepsy

From Genes and Molecules to Promising Therapies

  • Book
  • © 2013

Overview

  • Contains the most up-to-date information on the development of pharmacoresistance in epileptic disorders

  • Discusses novel therapeutic strategies to counteract the development of pharmacoresistance

  • Of interest to both basic scientists and clinicians?

  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

Keywords

About this book

Although more than 10 new antiepileptic drugs have been developed in the past decade, epilepsy remains resistant to drug therapy in about one third of patients, many of whom struggle with the disease their entire lives. Managing these patients is a challenge and requires a structured multidisciplinary approach. The book includes chapters on all issues related to pharmacoresistance in epilepsy and describes recent developments in the pathogenesis and treatment of this disorder. It addresses abnormalities in inhibitory mechanisms, epilepsy-related changes to the immune system, development of pharmacoresistance caused by chronic exposure to antiepileptic drugs, and novel therapeutic strategies for preventing or slowing down the progression of the disease.

Clinicians and basic scientists alike will find up-to-date information on the development of pharmacoesistance, as well as reviews of mechanisms associated with epilepsy that may help them consider novel strategies for preventing the development of pharmacoresistance in the first place. The book also features information on new therapeutic strategies for control of epilepsy, such as transcutaneous electrical stimulation and virtual screening of new antiepileptic drugs. Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies is useful to anyone working in the field, whether they’re studying epilepsy in the lab or treating it in a doctor’s office.”

Editors and Affiliations

  • , Pharmacobiology Department, Center for Research and Advanced Studies, Mexico City, Mexico

    Luisa Rocha

  • , Disciplina de Neurologia Experimental, UNIFESP/EPM, São Paulo, Brazil

    Esper A. Cavalheiro

Bibliographic Information

  • Book Title: Pharmacoresistance in Epilepsy

  • Book Subtitle: From Genes and Molecules to Promising Therapies

  • Editors: Luisa Rocha, Esper A. Cavalheiro

  • DOI: https://doi.org/10.1007/978-1-4614-6464-8

  • Publisher: Springer New York, NY

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2013

  • Hardcover ISBN: 978-1-4614-6463-1Published: 07 May 2013

  • eBook ISBN: 978-1-4614-6464-8Published: 08 July 2014

  • Edition Number: 1

  • Number of Pages: XII, 329

  • Topics: Neurosciences, Neurology, Pharmacology/Toxicology

Publish with us